This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
While the demand seemingly outpaces the industry’s ability to produce treatments for the pandemic, the quest to develop the “silver bullet” against COVID-19 is expected to drive competition in the industry. This fierce competition is predicted to propel the U.S. Volkan Gunduz, Associate Director of CI, Sanofi Genzyme.
In this blog, we briefly analyze some of the significant single-award IDIQs awarded by the GSA, highlighting their scope, stakeholders, and the diverse tasks they encompass, so that you can better navigate this landscape and understand the competitive environment. Over the next few years, several of these vehicles are due to be recompeted.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
104 
Let's personalize your content